CD109 / CPAMD7 antibody
Principal name
CD109 / CPAMD7 antibody
Alternative names for CD109 / CPAMD7 antibody
p180, r150, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7, 150 KDa TGF-beta-1-binding protein, Platelet-specific Gov antigen
Ncbi ID
9606, NP_001153059, AAI52997.1, NP_001153059.1, NP_694738.1, NM_153098, NM_133493, NM_001159588, NM_001159587
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB), Flow Cytometry (F), Enzyme Immunoassay (E), Paraffin Sections (P)
Background of CD109 / CPAMD7 antibody
- Kit Component:
- - KN302860G1, Cd109 gRNA vector 1 in pCas-Guide vector
- KN302860G2, Cd109 gRNA vector 2 in pCas-Guide vector
- KN302860D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Western Blot analysis of CD109 expression in transfected 293T cell line (H00135228-T02) by CD109 MaxPab polyclonal antibody.Lane 1: CD109 transfected lysate(158.95 KDa).Lane 2: Non-transfected lysate.
A typical staining pattern with the B-E47 monoclonal antibody of Eahy 926 cell line
A typical staining pattern with the B-E47 monoclonal antibody of Eahy cell line
A typical staining pattern with the B-E47 monoclonal antibody of Eahy 926 cell line
CD109 Antibody (N-term) (Cat. #AP50836PU-N) western blot analysis in mouse cerebellum tissue lysates (35µg/lane).This demonstrates the CD109 antibody detected the CD109 protein (arrow).
The image on the left is immunohistochemistry of paraffin-embedded Human liver cancer tissue using (CD109 Antibody) at dilution 1/30, on the right is treated with synthetic peptide. (Original magnification: ×200)
The image on the left is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using (CD109 Antibody) at dilution 1/30, on the right is treated with synthetic peptide. (Original magnification: ×200)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA350803 | CD109 / CPAMD7 antibody |
||||||
| Rabbit Polyclonal Anti-CD109 Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu | E, P |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
| AM31244AF-N | CD109 / CPAMD7 antibody |
||||||
 |
Mouse | IgG1 | B-E47 | Azide Free | Hu | F |
0.2 mg /
€350.00
|
| OriGene Technologies GmbH | |||||||
| AM31244PU-N | CD109 / CPAMD7 antibody |
||||||
 |
Mouse | IgG1 | B-E47 | Azide Free | Hu | F |
2ml (200T) /
€320.00
|
| OriGene Technologies GmbH | |||||||
| AM31244RP-N | CD109 / CPAMD7 antibody |
||||||
 |
Mouse | IgG1 | B-E47 | PE | Hu | F |
1ml (100T) /
€390.00
|
| OriGene Technologies GmbH | |||||||
| AP50836PU-N | CD109 / CPAMD7 (N-term) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu, Ms | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
CRISPR
| Catalog No. | Species | Donor Vector | |
|---|---|---|---|
| KN213359 | CD109 - human gene knockout kit via CRISPR |
||
 |
Human | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN213359BN | CD109 - human gene knockout kit via CRISPR |
||
|
Human | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN213359LP | CD109 - human gene knockout kit via CRISPR |
||
|
Human | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN213359RB | CD109 - human gene knockout kit via CRISPR |
||
|
Human | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
Human Lenti ORF Particles
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR211990L2V | Lenti ORF particles, Cd109 (GFP-tagged) - Mouse CD109 antigen (Cd109), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,500.00
|
|
| OriGene Technologies, Inc. | ||
| MR211990L1V | Lenti ORF particles, Cd109 (Myc-DDK-tagged) - Mouse CD109 antigen (Cd109), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,260.00
|
|
| OriGene Technologies, Inc. | ||